✦ LIBER ✦

P2.111 Anti-dyskinetic effects of flibanserin on levodopa-induced dyskinesia in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease

✍ Scribed by M. Gerlach; J. Beck; P. Riederer; M. van den Buuse

Book ID: 117753665
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 57 KB
Volume: 15
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(09)70462-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Flibanserin attenuatesl-DOPA-sensitized

Flibanserin attenuatesl-DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson’s disease

✍ Manfred Gerlach; Jürgen Beck; Peter Riederer; Maarten van den Buuse 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 219 KB

Effect of memantine on L-DOPA-induced dy

Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease

✍ Tronci, E.; Fidalgo, C.; Zianni, E.; Collu, M.; Stancampiano, R.; Morelli, M.; G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 761 KB

P.1.g.015 The role of valproic acid and

P.1.g.015 The role of valproic acid and levodopa on oxidative stress in a 6-hydroxydopamine lesioned rat model of Parkinson's disease

✍ Dagdelen, M.; Akkaya, H.; Genc, E. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Neurotoxic effects of berberine on long-

Neurotoxic effects of berberine on long-terml-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease

✍ Shin, Keon Sung; Choi, Hyun Sook; Zhao, Ting Ting; Suh, Kwang Hoon; Kwon, Ik Hyu 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 424 KB

Effect of histamine H2 receptor antagoni

Effect of histamine H2 receptor antagonism on levodopa–induced dyskinesia in the MPTP-macaque model of Parkinson's disease

✍ Tom H. Johnston; Anne van der Meij; Jonathan M. Brotchie; Susan H. Fox 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 823 KB

## Abstract Levodopa‐induced motor complications, including dyskinesia and wearing off, are troublesome side effects of treatment and impair quality of life in Parkinson's disease (PD) patients. The use of nondopaminergic agents as adjuncts to levodopa are potential options for managing these probl

Role of receptor heterodimers in the dev

Role of receptor heterodimers in the development of l-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease

✍ Chiara Fiorentini; Chiara Busi; PierFranco Spano; Cristina Missale 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 403 KB